Zobrazeno 1 - 10
of 94
pro vyhledávání: '"ingavirin®"'
Publikováno v:
Антибиотики и Химиотерапия, Vol 67, Iss 11-12, Pp 10-15 (2023)
Сhikungunya virus (CHIKV) is a member of the Flavivirus genus, Flaviviridae family. It belongs to the zoonotic arbovirus infections transmitted by mosquitoes of the genus Aedes. In humans, this flavivirus causes a disease known as Сhikungunya feve
Externí odkaz:
https://doaj.org/article/b5ceee115d80439f94192bed14ea2d32
Publikováno v:
Инфекция и иммунитет, Vol 11, Iss 6, Pp 1159-1166 (2022)
Influenza is a serious public health problem. The ability of influenza virus to change upon replication is the most serious issue for practical medicine and virology, which can fundamentally alter virus biological properties, such as infectivity and
Externí odkaz:
https://doaj.org/article/769e1900a253428091c3e068518267ca
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 98, Iss 5, Pp 548-557 (2021)
Introduction. The antiviral properties of imidazolyl ethanamide pentandioic acid (IPA), the active compound of the drug product, has been proven in various experimental models. However, the literature data on the toxicological properties of IPA are l
Externí odkaz:
https://doaj.org/article/d386a2531a044f70afc8c008b33bacdd
Publikováno v:
Терапевтический архив, Vol 93, Iss 1, Pp 114-124 (2021)
Routinely the influenza virus significantly contributes to the formation of the annual incidence of acute respiratory infections, with a peak in winter season. The high level of mutagenic potential of influenza viruses is a standard factor determinin
Externí odkaz:
https://doaj.org/article/1ae2f3ac90894778883e8d33ea0a5d11
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 3-4, Pp 8-11 (2020)
The protective activity of Ingavirin® against experimental infection caused by influenza B virus was studied on albino mice vs. Arbidol®. Oral use of Ingavirin® was shown to decrease the infectious titers of the virus in the animal lung tissue, to
Externí odkaz:
https://doaj.org/article/16b4294b7db64f0cb2a1856d174b9b15
Autor:
L. N. Shishkina, V. E. Nebolsin, A. S. Kabanov, M. O. Skarnovich, U. B. Erdyneeva, N. A. Mazurkova, O. A. Serova, E. A. Stavsky, I. G. Drozdov
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 3-4, Pp 12-16 (2020)
Ingavirin® was shown to be efficient in inhibition of the influenza virus strains A/California/04/2009 (H1N1)v, A/California/07/2009 (H1N1)v, A/Moscow/225/2009 (H1N1)v and A/Moscow/226/2009 (H1N1)v, as well as the strains A/Chicken/Kurgan/05/2005 (H
Externí odkaz:
https://doaj.org/article/986bfd46b275476399ff5cb610373495
Autor:
V. V. Zarubaev, A. V. Garshinina, N. A. Kalinina, A. A. Shtro, S. V. Belyaevskaya, V. E. Nebolsin, O. I. Kiselev
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 5-6, Pp 24-31 (2020)
Despite obvious success in the vaccine development and chemotherapy of influenza, it remains a poorly controlled infection leading to emergence of new pandemic variants of the virus with high morbidity and mortality. We investigated the protective ac
Externí odkaz:
https://doaj.org/article/4bf62812e6ba4ce88704c606d51bb76b
Autor:
L. N. Shishkina, V. E. Nebolsin, M. O. Skarnovich, A. S. Kabanov, A. A. Sergeev, U. B. Erdyneeva, O. A. Serova, O. K. Demina, A. P. Agafonov, E. A. Stavsky, I. G. Drozdov
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 5-6, Pp 32-35 (2020)
Ingavirin® was shown to be efficient in inhibition of the pandemic influenza virus strains A/California/04/2009 (H1N1)v, A/California/07/2009 (H1N1)v, A/Moscow/225/2009 (H1N1)v and A/Moscow/226/2009 (H1N1)v. as well as the influenza virus strain A/A
Externí odkaz:
https://doaj.org/article/6d97f88580d04a5582096225af9f838e
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 9-10, Pp 19-24 (2020)
Antiviral properties of Ingavirin® were investigated in the Hep-2 cell culture with respect to the human respiratory tract virus (type 5 adenovirus). In concentrations of Ingavirin® of 1000, 100 and 10 mcg/ml the generated posterity showed lower in
Externí odkaz:
https://doaj.org/article/6fa6e357ca0c46c8bcf01840dc9238d5
Publikováno v:
Антибиотики и Химиотерапия, Vol 64, Iss 1-2, Pp 9-13 (2020)
The experiment on guinea pigs shows that Ingavirin, when administered orally in a single dose of 15 mg/kg on the 4 th day after vaccination with TEOVac, reduces accumulation of vaccine virus in organs and tissues of animals without affecting the immu
Externí odkaz:
https://doaj.org/article/c3dae5d1df2b4fbc94a3498c03de9f5a